Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Confirmatory, Controlled Clinical Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation

NCT01599923 is registered in ClinicalTrials.gov with Instituto Bioclon S.A. de C.V. as lead sponsor.

NCT NCT01599923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Confirmatory, Controlled Clinical Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation
Lead sponsor
Instituto Bioclon S.A. de C.V.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2005
Completion date
August 31, 2006
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scorpion sting envenomation